R.A. Williams Distributors (JMSE:RAWILL) - Stock Price, News & Analysis

RAWILL Stock Overview

Engages in the sale and distribution of pharmaceutical products.

RAWILL fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	2/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 89.5% below our estimate of its fair value

Revenue grew by 6.3% over the past year

Risk Analysis

Does not have a meaningful market cap (JMD2B)

R.A. Williams Distributors Limited Competitors

Indies Pharma Jamaica

JMSE:INDIES

JA$4.0b

Image Plus Consultants

JMSE:IPCL

JA$2.1b

Elite Diagnostic

JMSE:ELITE

JA$805.8m

Royal Sense

BSE:544143

₹911.4m

Price History & Performance

Summary of all time highs, changes and price drops for R.A. Williams Distributors
Historical stock prices
Current Share Price	JA$0.87
52 Week High	JA$0.99
52 Week Low	JA$0.66
Beta	0
11 Month Change	-5.43%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	6.10%

Recent updates

Shareholder Returns

	RAWILL	JM Healthcare	JM Market
7D	-3.3%	3.1%	2.6%
1Y	n/a	-8.0%	5.2%

Return vs Industry: Insufficient data to determine how RAWILL performed against the JM Healthcare industry.

Return vs Market: Insufficient data to determine how RAWILL performed against the JM Market.

Price Volatility

Is RAWILL's price volatile compared to industry and market?
RAWILL volatility
RAWILL Average Weekly Movement	9.1%
Healthcare Industry Average Movement	6.4%
Market Average Movement	8.6%
10% most volatile stocks in JM Market	16.9%
10% least volatile stocks in JM Market	4.0%

Stable Share Price: RAWILL has not had significant price volatility in the past 3 months compared to the JM market.

Volatility Over Time: Insufficient data to determine RAWILL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2009	70	Audley Reid	rawilliamsltd.com

R.A. Williams Distributors Limited engages in the sale and distribution of pharmaceutical products. The company sells a range of prescription and non-prescription pharmaceutical products in the therapeutic areas of vision care, cardiovascular, central nervous system, respiratory, gastroenterology, dermatology, cough, cold and allergies, anti-infectives, oral care, intravenous solutions, parenteral nutrition, vitamins and minerals, and first aid. The company was incorporated in 2009 and is based in Spanish Town, Jamaica.

R.A. Williams Distributors Limited Fundamentals Summary

How do R.A. Williams Distributors's earnings and revenue compare to its market cap?
RAWILL fundamental statistics
Market cap	JA$1.74b
Earnings (TTM)	JA$84.65m
Revenue (TTM)	JA$1.50b

20.6x

P/E Ratio

1.2x

P/S Ratio

Is RAWILL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RAWILL income statement (TTM)
Revenue	JA$1.50b
Cost of Revenue	JA$803.75m
Gross Profit	JA$693.15m
Other Expenses	JA$608.50m
Earnings	JA$84.65m

Last Reported Earnings

Apr 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.042
Gross Margin	46.31%
Net Profit Margin	5.66%
Debt/Equity Ratio	69.8%

How did RAWILL perform over the long term?

See historical performance and comparison

R.A. Williams Distributors JMSE:RAWILL Stock Report